Filing Details
- Accession Number:
- 0001237899-10-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-04 12:00:00
- Reporting Period:
- 2010-02-02
- Filing Date:
- 2010-02-04
- Accepted Time:
- 2010-02-04 18:34:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1226687 | William Roberts | 777 Old Saw Mill River Road Tarrytown NY 10591 | Vp Regul Devel & Med Safety | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-02-02 | 5,000 | $13.00 | 71,956 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-02-02 | 5,000 | $27.48 | 66,956 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-02-02 | 7,000 | $13.00 | 73,956 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-02-02 | 3,350 | $27.16 | 70,606 | No | 4 | F | Direct | |
Common Stock | Disposition | 2010-02-02 | 1,321 | $27.16 | 69,285 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2010-02-03 | 1,500 | $13.00 | 70,785 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-02-03 | 695 | $28.02 | 70,090 | No | 4 | F | Direct | |
Common Stock | Disposition | 2010-02-03 | 291 | $28.02 | 69,799 | No | 4 | F | Direct | |
Common Stock | Disposition | 2010-02-03 | 194 | $28.08 | 69,605 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-02-03 | 2,135 | $27.66 | 67,470 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-02-04 | 43 | $28.38 | 67,427 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-02-04 | 471 | $27.48 | 66,956 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2010-02-02 | 5,000 | $0.00 | 5,000 | $13.00 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-02-02 | 7,000 | $0.00 | 7,000 | $13.00 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-02-03 | 1,500 | $0.00 | 1,500 | $13.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-12-15 | No | 4 | M | Direct | |
1,500 | 2013-12-15 | No | 4 | M | Direct | |
0 | 2013-12-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,200 | Indirect | by trust for daught |
Common Stock | 3,492 | Indirect | By 401(k) Plan |
Common Stock | 8,106 | Indirect | by Spouse |
Common Stock | 1,200 | Indirect | by trust for daught |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- The reporting person sold 2,135 shares of Company stock on February 3, 2010 at prices ranging from $27.41 to $27.98. Upon request by the Commission staff, the Company, or a security holder of the Company, we will provide full information regarding the number of shares sold by the reporting person on February 3, 2010 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.